Practice-Changing PARP Inhibitor Study in Ovarian Cancer
(MedPage Today) -- " Unprecedented " increase in PFS with upfront olaparib maintenance (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 21, 2018 Category: Hematology Source Type: news

' Outstanding' Ovarian Cancer PFS With Olaparib Maintenance'Outstanding' Ovarian Cancer PFS With Olaparib Maintenance
Patients with newly diagnosed advanced ovarian cancer have a marked increase in progression-free survival with maintenance olaparib after successful first-line chemotherapy, phase 3 study data indicates.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 21, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

AstraZeneca's Lynparza shown to put brakes on ovarian cancer
An AstraZeneca drug that blocks a cancer cell's ability to repair its genetic code greatly reduced the risk of ovarian cancer worsening in a phase III trial, underpinning its lead against two U.S. rivals in the same class. (Source: Reuters: Health)
Source: Reuters: Health - October 21, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Can Low-Dose Aspirin Lower Ovarian Cancer Risk?
Regular users of low-dose aspirin appear to have a reduced risk of developing ovarian cancer, according to a new study. (Source: CancerNetwork)
Source: CancerNetwork - October 20, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Why some cancers affect only young women
(Universit é de Gen è ve) Among several forms of pancreatic cancer, one of them affects specifically women, often young, even though the pancreas is an organ with little exposure to sex hormones. This pancreatic cancer, known as 'mucinous cyst,' has strange similarities with another mucinous cancer, affecting the ovaries. By conducting large-scale analyses of genomic data, researchers at the University of Geneva and at the University Hospitals of Geneva have provided an answer: both tumors originate from embryonic germ cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 19, 2018 Category: Cancer & Oncology Source Type: news

Ovarian cancer shame : Less than third of UK cases diagnosed
Worldwide ovarian cancer incidence is rising, and is expected to increase by 55 per cent by 2035. It is expected to go up by 15 per cent in the UK, according to predictions. (Source: the Mail online | Health)
Source: the Mail online | Health - October 18, 2018 Category: Consumer Health News Source Type: news

Diagnosis of ovarian cancer delayed by woeful lack of awareness
(World Ovarian Cancer Coalition) A global study of women with ovarian cancer has found that two thirds of women had never heard of the disease, or did not know anything about it before their diagnosis. Although nine out of ten had experienced symptoms prior to diagnosis, fewer than half of those women visited a doctor within a month of noticing symptoms. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 18, 2018 Category: Cancer & Oncology Source Type: news

Mother, 29, dies after battling ovarian cancer for five years
Gemma Nuttall, 29, from Rossendale, Lancashire, initially turned down cancer treatment because she was pregnant with Penelope and the drugs would have killed her unborn daughter. (Source: the Mail online | Health)
Source: the Mail online | Health - October 16, 2018 Category: Consumer Health News Source Type: news

UK Study Matches Mesothelioma Treatments to Genetic Profile
University of Leicester researchers soon will open the first molecularly stratified clinical trial for malignant mesothelioma with the hope of moving the future of treatment toward more personalization. The phase II trial in the United Kingdom is designed to match therapy with a patient’s specific genetic profile. “We’re trying to bring the right drug to the right patient at the right time,” Professor Dean Fennell, chair of thoracic medical oncology at Leicester and chief trial investigator, told Asbestos.com. “We need to find different treatments that work for different people. This is a step...
Source: Asbestos and Mesothelioma News - October 12, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Cinematic rendering enhances ovarian cancer evaluation
The photorealistic detail provided by cinematically rendered CT scans helped...Read more on AuntMinnie.comRelated Reading: Cinematic rendering bolsters AI for depth estimation on endoscopy Physicians prefer cinematic rendering for ankle injuries Cinematic rendering sheds light on abdominal pathology Cinematic rendering aids diagnosis in aortic complication Video from RSNA 2017: Cinematic rendering -- Just pretty pictures or paradigm shift? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 12, 2018 Category: Radiology Source Type: news

Low - Dose Aspirin May Reduce Ovarian Cancer Risk
Inverse association for low - dose but not standard - dose aspirin with ovarian cancer risk (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 12, 2018 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Oncology, Pharmacy, Journal, Source Type: news

Do siblings lower your cancer risk? People with big families are less likely to develop the disease
The larger the family, the less frequently certain types of cancer occur, including brain, bladder, lung, stomach, breast, ovarian colorectal and cervical cancers as well as melanoma. (Source: the Mail online | Health)
Source: the Mail online | Health - October 11, 2018 Category: Consumer Health News Source Type: news

Low-Dose Aspirin May Reduce Ovarian Cancer Risk
THURSDAY, Oct. 11, 2018 -- Low-dose aspirin use is associated with a reduced risk for ovarian cancer, according to a study published online Oct. 4 in JAMA Oncology. Mollie E. Barnard, Sc.D., from the Harvard T.H. Chan School of Public Health in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 11, 2018 Category: Pharmaceuticals Source Type: news

' Revolutionary' Data to Be Presented at ESMO 2018'Revolutionary' Data to Be Presented at ESMO 2018
Evolutions and even revolutions are expected when the latest data in head and neck cancer, renal cell carcinoma, breast cancer, and ovarian cancer are presented at the leading European cancer meeting.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 11, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Resources for Breast Cancer Awareness Month
Breast cancer affects 1 in every 8 women during their lives, and is the second most common kind of cancer in women. No one knows why some women get breast cancer, but there are many risk factors. Risks that you cannot change include: Age – the risk rises as you get older. Genes – two genes, BRCA1 and BRCA2, greatly increase the risk. Women who have family members with breast or ovarian cancer may wish to be tested for the genes. Personal factors – beginning periods before age 12 or going through menopause after age 55. For the month of October, help save lives in your community by sharing quality h...
Source: NN/LM Middle Atlantic Region Blog - October 10, 2018 Category: Databases & Libraries Authors: Hannah Sinemus Tags: Consumer Health Source Type: news

Crosstalk between fallopian tube, ovary may drive the spread of ovarian cancer
(University of Illinois at Chicago) New research shows that cancer cells in the fallopian tube affect normal chemical signaling between reproductive tissues and stimulate the release of norepinephrine from the ovary, causing cancer cells to migrate. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 9, 2018 Category: Cancer & Oncology Source Type: news

Regular Aspirin Use Curbs Risk of Cancers
Regular Aspirin Use Curbs Risk of Liver and Ovarian Cancer (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 5, 2018 Category: General Medicine Source Type: news

Low-Dose Aspirin May Protect Against Ovarian Cancer: Study
Title: Low-Dose Aspirin May Protect Against Ovarian Cancer: StudyCategory: Health NewsCreated: 10/4/2018 12:00:00 AMLast Editorial Review: 10/5/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - October 5, 2018 Category: Cancer & Oncology Source Type: news

How Does Hormonal Contraceptive Use Affect Ovarian Cancer Risk?
A study shows that combined hormonal contraceptive use is associated with a significant reduction in the risk of ovarian cancer. (Source: CancerNetwork)
Source: CancerNetwork - October 4, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Biomarker Associated With Longer Survival Uncovered in Ovarian Cancer
A new proteomic analysis found that CT45 is an independent prognostic factor in patients with high-grade serous ovarian cancer, and a potential target of immunotherapies. (Source: CancerNetwork)
Source: CancerNetwork - October 4, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Aspirin Use Tied to Reduced Risk of Liver, Ovarian Cancers
(MedPage Today) --'Strongest evidence to date'in hepatocellular carcinoma (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - October 4, 2018 Category: Gastroenterology Source Type: news

Regular Aspirin Use Curbs Risk of Liver and Ovarian Cancer Regular Aspirin Use Curbs Risk of Liver and Ovarian Cancer
Two new studies show that regular long-term aspirin use was linked to a lower risk of hepatocellular carcinoma and ovarian cancerMedscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 4, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Low-Dose Aspirin May Cut Ovarian Cancer Risk
Researchers say that women who reported recent, regular use of low-dose aspirin (100 milligrams or less) had a 23 percent lower risk of developing ovarian cancer than those who did not regularly take aspirin. (Source: WebMD Health)
Source: WebMD Health - October 4, 2018 Category: Consumer Health News Source Type: news

Low - Dose Aspirin May Protect Against Ovarian Cancer: Study
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 4, 2018 Category: Cancer & Oncology Tags: Family Medicine, Oncology, News, Source Type: news

Medical News Today: Ovarian cancer: Taking regular low-dose aspirin can lower risk
An analysis of data from two large cohorts totaling 205,498 women sees that regularly taking low-dose aspirin is linked to reduced risk of ovarian cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 4, 2018 Category: Consumer Health News Tags: Ovarian Cancer Source Type: news

Regular aspirin use can lower risk for ovarian, liver cancers
The regular use of aspirin was associated with a reduced risk of two deadly cancers -- ovarian and hepatocellular carcinoma. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 4, 2018 Category: Consumer Health News Source Type: news

Just quarter of an aspirin a day could slash a woman's ovarian cancer risk by 25%
A study of 205,000 women, led by Harvard University, found those who regularly took a quarter-dose painkiller were far less likely to be diagnosed with the cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - October 4, 2018 Category: Consumer Health News Source Type: news

Daily Baby Aspirin May Lower Ovarian Cancer Risk
A standard aspirin did not lower ovarian cancer risk. (Source: NYT Health)
Source: NYT Health - October 4, 2018 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Ovarian Cancer Aspirin Stroke Source Type: news

Daily low-dose aspirin may lower risk of ovarian cancer
Women who recently and regularly take a daily low-dose aspirin may lower their risk of developing ovarian cancer, new research suggests. (Source: CNN.com - Health)
Source: CNN.com - Health - October 4, 2018 Category: Consumer Health News Source Type: news

Low-Dose Aspirin May Protect Against Ovarian Cancer: Study
THURSDAY, Oct. 4, 2018 -- Regular use of low-dose aspirin may the reduce risk of ovarian cancer, a new study suggests. Researchers analyzed data from more than 205,000 American women and found that those who reported recent, regular use of low-dose... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 4, 2018 Category: General Medicine Source Type: news

Evidence mounts linking aspirin to lower risk of ovarian cancer
Taking a low-dose aspirin daily may help women lower their risk of developing ovarian cancer. A new study co-led by Moffitt Cancer Center found that women who reported taking a low-dose aspirin every day had a 23 percent lower risk of ovarian cancer compared to nonaspirin users. (Source: World Pharma News)
Source: World Pharma News - October 4, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Evidence mounts linking aspirin to lower risk of ovarian cancer
(H. Lee Moffitt Cancer Center& Research Institute) A new study found that women who reported taking a low-dose aspirin every day had a 23 percent lower risk of ovarian cancer compared to nonaspirin users. The research also found that women who were heavy users of nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen (Advil) or naproxen (Aleve), over a long period of time had a higher risk of developing ovarian cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 4, 2018 Category: Cancer & Oncology Source Type: news

Low-dose aspirin may lower ovarian cancer risk
(Harvard T.H. Chan School of Public Health) Women who reported recent, regular use of low-dose aspirin (100 milligrams or less) had a 23 percent lower risk of developing ovarian cancer when compared with women who did not regularly take aspirin, according to new research led by Harvard T.H. Chan School of Public Health. The study also found that long-term heavy use of non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) may be associated with an increased risk of ovarian cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 4, 2018 Category: Cancer & Oncology Source Type: news

Low-Dose Aspirin May Protect Against Ovarian Cancer: Study
(Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - October 4, 2018 Category: Cancer & Oncology Source Type: news

Discovery determines best PARPi treatment candidates for ovarian cancer
Scientists have figured out which ovarian cancer patients are best suited for drugs called PARP inhibitors. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 1, 2018 Category: Consumer Health News Source Type: news

Wearing a Pink Ribbon for Breast Cancer Awareness? Here ’s How Awareness Ribbons Became a Thing
With Monday marking the beginning of October’s annual Breast Cancer Awareness Month observance, supporters will be donning their pink ribbons as a show of support for ongoing research for a cure. It’s a ritual that repeats itself for any number of causes, such as teal ribbons for ovarian cancer to red ribbons for AIDS awareness. But when did ribbons begin to be used as symbols for various causes? The Library of Congress’s Folklife Center has studied the history of such awareness ribbons in American culture, and found that many citizens assume that the tradition is older than it is. Among the most frequen...
Source: TIME: Health - October 1, 2018 Category: Consumer Health News Authors: Olivia B. Waxman Tags: Uncategorized breast cancer news society Source Type: news

New cancer vaccine can teach the immune system to 'see' rogue cells
One woman treated with the vaccine, which teaches the immune system to recognise rogue cells, saw her ovarian cancer disappear for more than 18 months. (Source: the Mail online | Health)
Source: the Mail online | Health - September 30, 2018 Category: Consumer Health News Source Type: news

J & J Dodges Verdict in Mesothelioma Trial, Imerys Settles
Johnson & Johnson’s latest trial over claims its iconic baby powder causes mesothelioma ended in mistrial this week after a California jury couldn’t reach a decision in the case of school counselor Carolyn Weirick. Lawyers for Weirick asked jurors for $25 million in compensation for past and future pain and suffering related to her mesothelioma, a rare cancer linked to asbestos exposure. Weirick, 59, was diagnosed with mesothelioma in 2017 and said her only exposure to asbestos came from the use of J&J’s talc-based products for more than 40 years. A state judge in Pasadena, California, declared a ...
Source: Asbestos and Mesothelioma News - September 28, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Medical News Today: Ovarian cancer: Newer birth control pills may lower risk
A large study examines the effect of newer combined oral contraceptives on the risk of ovarian cancer among women of reproductive age. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 28, 2018 Category: Consumer Health News Tags: Ovarian Cancer Source Type: news

Newer birth control pills tied to lower risk of ovarian cancer
New research finds lower-dose combined hormonal contraceptives are associated with a reduced risk of ovarian cancer (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - September 27, 2018 Category: Consumer Health News Source Type: news

WATCH: 'GMA' Hot List: Birth control linked to lower ovarian cancer risk
ABC News chief medical correspondent Dr. Jennifer Ashton shares what women should know about the results of a study that followed women for 20 years. (Source: ABC News: Health)
Source: ABC News: Health - September 27, 2018 Category: Consumer Health News Tags: GMA Source Type: news

Newer Hormonal Contraception May Cut Ovarian Cancer Risk
Combined hormonal contraception use tied to lower risk; risk down with increasing duration of use (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 27, 2018 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Nursing, Oncology, Pharmacy, Journal, Source Type: news

Use of combined birth control linked to lower risk of ovarian cancer
Birth control pills, patches and rings that combine estrogen and progestin linked to reduced risk for ovarian cancer, says study. (Source: CNN.com - Health)
Source: CNN.com - Health - September 27, 2018 Category: Consumer Health News Source Type: news

Women taking the combined pill have a lower risk of ovarian cancer
Researchers from the University of Aberdeen and University of Copenhagen studied around 1.9 million Danish women to find the combined pill is best at preventing ovarian cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - September 27, 2018 Category: Consumer Health News Source Type: news

WATCH: Newer hormonal birth control linked to lower ovarian cancer risk: Study
Dr. Jennifer Ashton discusses what to know about a new report that found using hormonal contraception was associated with significantly lower risks of developing ovarian cancer. (Source: ABC News: Health)
Source: ABC News: Health - September 27, 2018 Category: Consumer Health News Tags: GMA Source Type: news

WATCH: Newer hormonal birth control linked to lower ovarian cancer risk: Study
Hormonal contraception methods like a pill, patch, ring or injectable are very effective and popular as birth control, but they can have other health benefits, too. (Source: ABC News: Health)
Source: ABC News: Health - September 27, 2018 Category: Consumer Health News Tags: Health Source Type: news

Hormonal contraceptives lower ovarian cancer risk
Research, published inThe BMJ, suggests that women who use the hormonal contraceptive pill have a lower risk of developing ovarian cancer.The Guardian (Source: Society for Endocrinology)
Source: Society for Endocrinology - September 27, 2018 Category: Endocrinology Source Type: news

Newer Birth Control Pills Tied to Lower Odds for Ovarian Cancer
Title: Newer Birth Control Pills Tied to Lower Odds for Ovarian CancerCategory: Health NewsCreated: 9/26/2018 12:00:00 AMLast Editorial Review: 9/27/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - September 27, 2018 Category: Cancer & Oncology Source Type: news

Newer Birth Control Pills Tied to Lower Odds for Ovarian Cancer
The protective effect of newer birth control pills -- which contain lower doses of estrogens and different progestogens -- rise over time and persist for several years after women stopped taking them, new research finds. (Source: WebMD Health)
Source: WebMD Health - September 27, 2018 Category: Consumer Health News Source Type: news